Radioligand Therapy With <superscript>177</superscript>Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer: Oncological Outcomes and Toxicity Profile.
In: Clinical Nuclear Medicine, Jg. 48 (2023-12-01), Heft 12, S. e564- (6S.)
academicJournal
Zugriff:
Titel: |
Radioligand Therapy With <superscript>177</superscript>Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer: Oncological Outcomes and Toxicity Profile.
|
---|---|
Autor/in / Beteiligte Person: | Demirkol, Mehmet Onur ; Esen, Barış ; Seymen, Hülya ; Şen, Melis ; Uçar, Burcu ; Kurtuldu, Sevgilay ; Mandel, Nil Molinas ; Bavbek, Sevil ; Falay, Okan ; Tilki, Derya ; Esen, Tarık |
Zeitschrift: | Clinical Nuclear Medicine, Jg. 48 (2023-12-01), Heft 12, S. e564- (6S.) |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0363-9762 (print) |
DOI: | 10.1097/RLU.0000000000004901 |
Sonstiges: |
|